Dina Ruano Selected Research

Dina Ruano Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 06/2013
10	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 03/2015
5	Schizophrenia (Dementia Praecox) 01/2012 - 07/2004
3	Neoplasm Metastasis (Metastasis) 10/2023 - 03/2015
3	Carcinoma (Carcinomatosis) 01/2019 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 06/2013
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 01/2018
2	Adenoma (Adenomas) 01/2019 - 08/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2024
1	Lymphoma (Lymphomas) 10/2023
1	Melanoma (Melanoma, Malignant) 10/2023
1	Venous Thromboembolism 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Adenocarcinoma 11/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Carcinogenesis 01/2019
1	Polyps 01/2019
1	follicular Thyroid cancer 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 02/2015
1	Monosomy 01/2012
1	Papillary Thyroid Cancer 01/2012
1	Mental Disorders (Mental Disorder) 01/2012
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2009
1	Flushing 07/2007

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2008
4	EpitopesIBA 11/2022 - 10/2019
3	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2020
3	Calcibiotic Root Canal SealerIBA 01/2023 - 07/2016
3	Exonucleases (3' 5' Exonuclease)IBA 01/2019 - 08/2015
3	Formaldehyde (Formol)FDA Link 01/2018 - 06/2013
3	ParaffinIBA 01/2018 - 06/2013
2	AntigensIBA 10/2023 - 10/2019
2	Peptides (Polypeptides)IBA 10/2022 - 10/2019
2	RacivirIBA 01/2018 - 01/2012
2	Messenger RNA (mRNA)IBA 09/2017 - 06/2013
1	Polyketide SynthasesIBA 01/2024
1	MutagensIBA 01/2024
1	colibactinIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	InterferonsIBA 11/2022
1	MHC class II transactivator proteinIBA 10/2022
1	Galectin 3 (LGALS3)IBA 06/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2022
1	B7-H1 AntigenIBA 06/2022
1	carboxyl radical (COO-)IBA 03/2022
1	Mismatch Repair Endonuclease PMS2IBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 02/2015
1	NucleotidesIBA 02/2015
1	Thyroid HormonesIBA 01/2012
1	UbiquitinIBA 04/2009
1	CalcineurinIBA 01/2008
1	NeurograninIBA 01/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2008
1	Prealbumin (Transthyretin)IBA 10/2007
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 07/2007
1	Niacin (Nicotinic Acid)FDA LinkGeneric 07/2007
1	LipidsIBA 07/2007
1	Prostaglandin D2IBA 07/2007
1	EnzymesIBA 07/2007
1	LipocalinsIBA 07/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2004

Therapy/Procedure

8	Immunotherapy 10/2023 - 01/2019
3	Therapeutics 10/2019 - 03/2016
1	Drug Therapy (Chemotherapy) 11/2022
1	Radiotherapy 01/2021
1	Traction 01/2021
1	Ligation 01/2018